Benzodiazepine Class Confirmation Urine
Order Name
BENZO CONF
Test Number: 4000425
Revision Date 05/14/2020
Test Number: 4000425
Revision Date 05/14/2020
Test Name | Methodology | LOINC Code |
---|---|---|
Alprazolam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 59615-5 |
Alprazolam Interpretation
|
Interpretive information. | |
Alpha Hydroxyalprazolam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 16348-5 |
Alpha Hydroxyalprazolam Interpretation
|
Interpretive information. | |
Triazolam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 16232-1 |
Triazolam Interpretation
|
Interpretive information. | |
Alpha Hydroxytriazolam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 49876-6 |
Alpha Hydroxytriazolam Interpretation
|
Interpretive information. | |
Flunitrazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 20528-6 |
Flunitrazepam Interpretation
|
Interpretive information. | |
7 Aminoflunitrazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 51777-1 |
7 Aminoflunitrazepam Interpretation
|
Interpretive information. | |
Clonazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 16229-7 |
Clonazepam Interpretation
|
Interpretive information. | |
7 Aminoclonazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 51776-3 |
7 Aminoclonazepam Interpretation
|
Interpretive information. | |
Flurazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 16231-3 |
Flurazepam Interpretation
|
Interpretive information. | |
Des Alkyl Flurazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 16230-5 |
Des Alkyl Flurazepam Interpretation
|
Interpretive information. | |
Diazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 16227-1 |
Diazepam Interpretation
|
Interpretive information. | |
Nordiazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 16228-9 |
Nordiazepam Interpretation
|
Interpretive information. | |
Lorazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 17088-6 |
Lorazepam Interpretation
|
Interpretive information. | |
Oxazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 16201-6 |
Oxazepam Interpretation
|
Interpretive information. | |
Temazepam Confirmation
|
Liquid Chromatography/Mass Spectroscopy | 20559-1 |
Temazepam Interpretation
|
Interpretive information. |
SPECIMEN REQUIREMENTS | ||||
---|---|---|---|---|
Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
Preferred | 10 mL (1 mL) | Urine, Random | Sterile Container or Monovette | Refrigerated |
Instructions | Keep refrigerated. Specimen Stability: Ambient 7 days. Refrigerated 30 days. Frozen 6 months Please provide accurate prescription list to lab. |
GENERAL INFORMATION | |
---|---|
Testing Schedule | Mon - Fri |
Expected TAT | 3-5 days |
Clinical Use | Used to evaluate medication compliance in pain management. |
CPT Code(s) | G0480 (alternate:80347) |
Lab Section | Chemistry LC-MS |